RBOT

Vicarious Surgical Inc.

NYSE: RBOT · HEALTHCARE · MEDICAL DEVICES

$0.01

-44.00% today

Updated 2026-10-30

Market cap

$7.07M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-6.62

Dividend yield

—

52W range

$0 – $14

Volume

0.0M

Market cap

$7.07M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-6.62

Dividend yield

—

52W range

$0 – $14

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

$5.00

+59423.81%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-6.33M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$5.16M	$-71.07M	$-63.22M	$-50.18M	$-7.33M
EPS	—	—	—	—	$-6.62
Free cash flow	$-66.56M	$-63.98M	$-50.14M	$-45.21M	$-6.33M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RBOT	$7.07M	23	4.3	3.0	5.0	5.0	—	Avoid
LLY	$1.26T	74	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$657.68B	54	4.7	8.5	2.7	5.5	-89.35%	Buy
ABBV	$521.11B	77	6.7	9.0	4.0	5.0	-88.02%	Strong Buy
MRK	$368.89B	44	3.3	6.5	2.0	5.0	-76.61%	Hold
UNH	$365.29B	62	6.7	6.0	4.7	5.5	-24.78%	Buy

Smart narrative

Vicarious Surgical Inc. trades at $0.01. Our Smart Value Score of 23/100 indicates the stock is weak.

Frequently asked questions

What is Vicarious Surgical Inc.'s stock price?

Vicarious Surgical Inc. (RBOT) trades at $0.01.

Is Vicarious Surgical Inc. overvalued?

Vicarious Surgical Inc. carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Vicarious Surgical Inc. (RBOT)?

The 12-month analyst consensus target is $5.00, about 59423.8% above the current $0.01. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNYSE

CurrencyUSD

Quick metrics

P/S ratio—

ROE-177.50%

Beta1.82

50D MA$0.73

200D MA$3.19

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

RBOT vs LLY →RBOT vs JNJ →RBOT vs ABBV →Stock screener →